Loss and seroconversion of hepatitis B surface antigen after vaccine therapy in chronic hepatitis B patients treated with nucleoside/nucleotide analogues

Authors
Category Primary study
ConferenceHepatology International
Year 2013
This article has no abstract
Epistemonikos ID: b5d09f2ed29d2ab8989bd67c80ac2d19c787496c
First added on: Apr 30, 2026